Volume 4 Issue 11 of 𝘕𝘌𝘑𝘔 𝘌𝘷𝘪𝘥𝘦𝘯𝘤𝘦 is now available! Here is a preview of the latest content: 𝗢𝗿𝗶𝗴𝗶𝗻𝗮𝗹 𝗔𝗿𝘁𝗶𝗰𝗹𝗲𝘀 Cardiac Effects of Dapagliflozin in People with Chronic Kidney Disease https://t.co/UZvHJetjv0

Happy to see the main results from our DECODE-CKD trial published in @NEJMEvidence. Yet another unique trial from the @CTCPR_ team, and in particular congratulations to the coordinating investigator @katjabartholdy 👏 Please find the paper below 👇 https://t.co/uic19h6hsJ

🚨 Long-term AAS use dramatically raises cardiovascular risk 💥🫀 A new nationwide Danish study with @CTCPR_, published in @CircAHA, shows that men using anabolic–androgenic steroids (AAS) face substantially higher rates of cardiovascular disease compared with the general

🎓 The final keynote of #ESWI2025 featured Tor Biering-Sørensen (@TorBiering, University of Copenhagen, 🇩🇰) presenting the FLUNITY-HD study — a pooled analysis of the DANFLU-2 and GALFLU trials linking influenza vaccination to cardiovascular protection💉❤️ #Vaccines #PublicHealth

@CTCPR_ was well represented at #IDWeek with rising 🌟 @AM_reimer giving a LBCT presentation on the immunocompromised subgroup from the DAN-RSV trial and a poster presentation on the immunocompromised subgroup from the NUDGE-FLU CHRONIC trial. 👉 publications coming out soon.

🔬 @CTCPR_ FLUNITY-HD study, published in @TheLancet, reveals that the High-Dose influenza vaccine provides superior protection against hospitalisations compared to the conventional Standard-Dose. Nearly 500,000 participants aged 65+ were individually randomized — the first

Influenza and heart dysfunction 🫀🦠 A new interim analysis from the FluHeart Study by @CTCPR_ shows that patients with influenza frequently develop left and right ventricular dysfunction. Cardiac impairment was worse than in matched general population controls and comparable to

NUDGE-FLU trial: Promoting one vaccine can influence uptake of another 🦠💉 A prespecified secondary analysis of the nationwide NUDGE-FLU trial by @niklasdj1,  and colleagues @CTCPR_ found that electronic letters promoting influenza vaccination slightly reduced COVID-19

Infections can trigger heart attacks & strokes — but vaccines can serve as a preventative tool!🫀💉 A consensus between European Interdisciplinary Council for Aging (EICA) and the Italian Society for Cardiovascular Prevention (@SIPREC_it) , including @TorBiering from @CTCPR_,

RSV infection and cardiovascular risk 🫀 A nationwide @CTCPR_ study in @JACCJournals by @matslassen & colleagues shows adults ≥65 have a 4–8× higher risk of heart failure hospitalization and ischemic stroke in the 14 days after acute RSV infection. 💡 Highlights the need for

🫀 Global longitudinal strain (GLS) under the spotlight! A new @CTCPR_ study in @JACCJournals defines a key cutoff for patient risk: 📊 GLS < 16% is the lower normal limit across ultrasound vendors — and predicts heart failure hospitalization in elderly & at-risk individuals

🌍 New insights by @Espersen_C and colleagues @CTCPR_ | @CircAHA Cardiovascular disease (CVD) affects 11% of the Danish population and remains the second leading cause of death, responsible for ≈12,000 deaths annually. Despite Denmark’s universal healthcare, social and

🌍 Insights on heart hospitalizations in US vs Denmark from @CTCPR_ ! US has 1.5× higher rates, bigger income gaps, especially in MI & HF. Highlights how healthcare and social factors shape outcomes. 📊 Dive deeper: https://t.co/88E6SIxp8M @JAMACardio

Reunion time at #ESCCongress2025! ⁦@MananPareekMD⁩ ⁦@mvaduganathan⁩ ⁦@rkwadhera⁩

I’m more than proud to lead a team of the most talented researchers I have ever met 👩‍🎓🧑🏽‍🎓Congratulations to the whole team with this accomplishment 👏 It’s an honor to work with and learn from you all 🙏 @CTCPR_ for the win 🌟

.@TorBiering has entirely changed the game & transformed the clinical trial landscape! #DANFLU2 #GALFLU #DANRSV provide a glimpse at the possibilities of randomizing at scale & addressing fundamental unanswered questions. Hats off to @niklasdj1 @matslassen & entire @CTCPR_ team

🚨 An extraordinary achievement from all the @CTCPR_ researchers at ESC! Our researchers simultaneously published 13 papers across leading journals, showcasing some of the latest breakthroughs in cardiology. These publications include: · 3 in The New England Journal of Medicine

What an incredible #ESCCongress2025! Privileged to hang out with the likes of @DLBHATTMD @mvaduganathan @rkwadhera @RahulAggarwalMD and to call @TorBiering my boss! Three simpubs as 1st author will not be easy to top, but that is definitely the goal next year!

Editorial: Recent advancements and clinical trials emphasize the importance of recognizing #RSV as a health threat in older adults, with vaccines offering protection against severe disease and potentially broader cardiopulmonary benefits. #ESCCongress #WCCardio